On 5 June we reached an agreement with global investment firms Blackstone, Carlyle and Hellman & Friedman to make a majority investment in Medline. While the Mills family will remain the largest shareholder in Medline, these additional investors will allow us to deliver even more value to our customers.
Our plan is to use our increased resources and financial strength to expand our product offering, continue to fund our infrastructure expansion and strengthen our supply chain.
This partnership will accelerate Medline’s growth and internal expansion in particular, but most importantly, day-to-day business will remain the same. The Mills family will continue to lead the organisation, our entire management team will remain the same and our customer-facing employees will keep doing what they do best—putting the customer first in everything they do. Simply put, it remains business as usual at Medline. We are confident that we will maintain the family-led, customer-centric culture that our customers have recognised in us over the past 50 years.
The transaction should complete later this year, following regulatory approvals and customary closing conditions.
If you have any questions about this investment, please contact your existing account manager or our customer service team: [email protected].